Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 16;10(6):620-629.
doi: 10.1530/EC-21-0019.

The evolving role of whole-exome sequencing in the management of disorders of sex development

Yardena Tenenbaum-Rakover  1   2 , Osnat Admoni  1 , Ghadir Elias-Assad  1   2 , Shira London  1 , Marie Noufi-Barhoum  1   3 , Hanna Ludar  1 , Tal Almagor  1 , Yoav Zehavi  4 , Charles Sultan  5 , Rita Bertalan  6 , Anu Bashamboo  6 , Kenneth McElreavey  6
Affiliations

The evolving role of whole-exome sequencing in the management of disorders of sex development

Yardena Tenenbaum-Rakover et al. Endocr Connect. .

Abstract

Objective: Disorders of sex development (DSD) are defined as congenital conditions in which the development of chromosomal, gonadal and anatomical sex is atypical. Despite wide laboratory and imaging investigations, the etiology of DSD is unknown in over 50% of patients.

Methods: We evaluated the etiology of DSD by whole-exome sequencing (WES) at a mean age of 10 years in nine patients for whom extensive evaluation, including hormonal, imaging and candidate gene approaches, had not identified an etiology.

Results: The eight 46,XY patients presented with micropenis, cryptorchidism and hypospadias at birth and the 46,XX patient presented with labia majora fusion. In seven patients (78%), pathogenic variants were identified for RXFP2, HSD17B3, WT1, BMP4, POR, CHD7 and SIN3A. In two atients, no causative variants were found. Mutations in three genes were reported previously with different phenotypes: an 11-year-old boy with a novel de novo variant in BMP4; such variants are mainly associated with microphthalmia and in few cases with external genitalia anomalies in males, supporting the role of BMP4 in the development of male external genitalia; a 12-year-old boy with a known pathogenic variant in RXFP2, encoding insulin-like 3 hormone receptor, and previously reported in adult men with cryptorchidism; an 8-year-old boy with syndromic DSD had a de novo deletion in SIN3A.

Conclusions: Our findings of molecular etiologies for DSD in 78% of our patients indicate a major role for WES in early DSD diagnosis and management - and highlights the importance of rapid molecular diagnosis in early infancy for sex of rearing decisions.

Keywords: bone morphogenetic protein 4; disorders of sex development; insulin-like 3 hormone receptor; whole-exome sequencing.

PubMed Disclaimer

References

    1. Houk CP, Lee PA. Consensus statement on terminology and management: disorders of sex development. Sexual Development: Genetics, Molecular Biology, Evolution, Endocrinology, Embryology, and Pathology of Sex Determination and Differentiation 2008. 2 172–180. ( 10.1159/000152032) - DOI - PubMed
    1. Ahmed SF, Dobbie R, Finlayson AR, Gilbert J, Youngson G, Chalmers J, Stone D.Prevalence of hypospadias and other genital anomalies among singleton births, 1988–1997, in Scotland. Archives of Disease in Childhood: Fetal and Neonatal Edition 2004. 89 F149–F151. ( 10.1136/adc.2002.024034) - DOI - PMC - PubMed
    1. Rodie M, McGowan R, Mayo A, Midgley P, Driver CP, Kinney M, Young D, Ahmed SF.Factors that influence the decision to perform a karyotype in suspected disorders of sex development: lessons from the Scottish genital anomaly network register. Sexual Development: Genetics, Molecular Biology, Evolution, Endocrinology, Embryology, and Pathology of Sex Determination and Differentiation 2011. 5 103–108. ( 10.1159/000326815) - DOI - PubMed
    1. Hiort O, Gillessen-Kaesbach G. Disorders of sex development in developmental syndromes. In Endocrine Involvement in Developmental Syndromes, vol 14, ch 12, pp 174–180. Eds Cappa M, Maghnie M, Loche S, Bottazzo GF.Basel: Karger 2009. ( 10.1159/000207486) - DOI - PubMed
    1. Audi L, Ahmed SF, Krone N, Cools M, McElreavey K, Holterhus PM, Greenfield A, Bashamboo A, Hiort O, Wudy SA, et al. The EU COST Action. Approaches to molecular genetic diagnosis in the management of differences/disorders of sex development (DSD): position paper of EU COST Action BM 1303 ‘DSDnet’. European Journal of Endocrinology 2018. 179 R197–R206. ( 10.1530/EJE-18-0256) - DOI - PMC - PubMed

LinkOut - more resources